Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
C7196 Chelidamic acid -
B8796 RS 09 TFA -
B8902 TXNIP-IN-1 -
B8905 Adenosine 5'-monophosphate disodium -
B8918 Resmetirom -
A4015 Disulfiram2 CitationTarget: Aldehyde DehydrogenasesSummary: Dopamine β-hydroxylase inhibitor -
A4054 17-AAG (KOS953)3 CitationSummary: Hsp90 inhibitor -
A4056 AT13387Target: HSP90Summary: Hsp90 inhibitor -
A4057 AUY922 (NVP-AUY922)1 CitationTarget: HSP90Summary: Potent Hsp90 inhibitor -
A4058 BIIB021Target: HSP90Summary: Hsp90 inhibitor,selective and competitive

